Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Utility of S100B Protein Concentration for Diagnosing Fetal Central Nervous System Hypoxia-Ischemia in Children With Late Fetal Growth Retardation: A Prospective Cohort Study

NCT06893926 is registered in ClinicalTrials.gov with Institute of Mother and Child, Warsaw, Poland as lead sponsor.

NCT NCT06893926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06893926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Utility of S100B Protein Concentration for Diagnosing Fetal Central Nervous System Hypoxia-Ischemia in Children With Late Fetal Growth Retardation: A Prospective Cohort Study
Lead sponsor
Institute of Mother and Child, Warsaw, Poland
Phase
Observational
Overall status
Recruiting
Start date
June 18, 2024
Completion date
March 31, 2026
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fetal growth restriction (fgr), hypoxia-ischemia, brain, s100b